Clinical Trial Update: Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab, etoposide, and cisplatin followed by whole brain radiotherapy for breast cancer with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Whole brain radiotherapy

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Breast Cancer, Brain Metastases | Phase 2 | Status: UNKNOWN